Citation: Kj. Price et al., PROGNOSTIC INDICATORS FOR BLOOD AND MARROW TRANSPLANT PATIENTS ADMITTED TO AN INTENSIVE-CARE UNIT, American journal of respiratory and critical care medicine, 158(3), 1998, pp. 876-884
Authors:
UENO NT
RONDON G
MIRZA NQ
GEISLER DK
ANDERLINI P
GIRALT SA
ANDERSSON BS
CLAXTON DF
GAJEWSKI JL
KHOURI IF
KORBLING M
MEHRA RC
PRZEPIORKA D
RAHMAN Z
SAMUELS BI
VANBESIEN K
HORTOBAGYI GN
CHAMPLIN RE
Citation: Nt. Ueno et al., ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION FOR POOR-RISK PATIENTS WITH METASTATIC BREAST-CANCER, Journal of clinical oncology, 16(3), 1998, pp. 986-993
Authors:
ANDERSSON BS
MARTINKA S
MCWILLIAMS K
HAI T
MOLLDREM J
BRUTON J
GIAN V
FERNANDEZ H
TARANTOLO S
KASHYAP A
FORMAN SJ
HU W
BLUME K
CAGNONI P
JONES R
CHAMPLIN RE
Citation: Bs. Andersson et al., THERAPY WITH IV BUSULFAN, CYTOXAN (BUCY) AND ALLOGENEIC HEMATOPOIETICSTEM-CELLS (HSC) FOR ADVANCED HEMATOLOGICAL MALIGNANCIES, Bone marrow transplantation, 21, 1998, pp. 333-333
Authors:
MUNKER R
ZHAO SR
JIANG SW
SNELL V
ANDREEFF M
ANDERSSON BS
Citation: R. Munker et al., FURTHER CHARACTERIZATION OF CYCLOPHOSPHAMIDE RESISTANCE - EXPRESSION OF CD95 AND OF BCL-2 IN A CML CELL-LINE, Leukemia research, 22(11), 1998, pp. 1073-1077
Authors:
CHOW DSL
BHAGWATWAR HP
PHADUNGPOJNA S
ANDERSSON BS
Citation: Dsl. Chow et al., STABILITY-INDICATING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY OFBUSULFAN IN AQUEOUS AND PLASMA SAMPLES, Journal of chromatography B. Biomedical sciences and applications, 704(1-2), 1997, pp. 277-288
Authors:
RAJS J
RASTENALMQVIST P
FALCK G
EKSBORG S
ANDERSSON BS
Citation: J. Rajs et al., SUDDEN-INFANT-DEATH-SYNDROME - POSTMORTEM FINDINGS OF NICOTINE AND COTININE IN PERICARDIAL FLUID OF INFANTS IN RELATION TO MORPHOLOGICAL-CHANGES AND POSITION AT DEATH, PEDIATRIC PATHOLOGY & LABORATORY MEDICINE, 17(1), 1997, pp. 83-97
Authors:
DIGNANI MC
ANAISSIE EJ
HESTER JP
OBRIEN S
VARTIVARIAN SE
REX JH
KANTARJIAN H
JENDIROBA DB
LICHTIGER B
ANDERSSON BS
FREIREICH EJ
Citation: Mc. Dignani et al., TREATMENT OF NEUTROPENIA-RELATED FUNGAL-INFECTIONS WITH GRANULOCYTE-COLONY-STIMULATING FACTOR-ELICITED WHITE BLOOD-CELL TRANSFUSIONS - A PILOT-STUDY, Leukemia, 11(10), 1997, pp. 1621-1630
Authors:
DELIMA M
VANBESIEN KW
GIRALT SA
KHOURI IF
MEHRA R
ANDERSSON BS
PRZEPIORKA D
GAJEWSKI JL
KORBLING M
CHAMPLIN RE
Citation: M. Delima et al., BONE-MARROW TRANSPLANTATION AFTER FAILURE OF AUTOLOGOUS TRANSPLANT FOR NON-HODGKINS-LYMPHOMA, Bone marrow transplantation, 19(2), 1997, pp. 121-127
Authors:
VANBESIEN KW
DELIMA M
GIRALT SA
MOORE DF
KHOURI IF
RONDON G
MEHRA R
ANDERSSON BS
DYER C
CLEARY K
PRZEPIORKA D
GAJEWSKI JL
CHAMPLIN RE
Citation: Kw. Vanbesien et al., MANAGEMENT OF LYMPHOMA RECURRENCE AFTER ALLOGENEIC TRANSPLANTATION - THE RELEVANCE OF GRAFT-VERSUS-LYMPHOMA EFFECT, Bone marrow transplantation, 19(10), 1997, pp. 977-982
Authors:
VERSCHRAEGEN CF
VANBESIEN KW
DIGNANI C
HESTER JP
ANDERSSON BS
ANAISSIE E
Citation: Cf. Verschraegen et al., INVASIVE ASPERGILLUS SINUSITIS DURING BONE-MARROW TRANSPLANTATION, Scandinavian journal of infectious diseases, 29(4), 1997, pp. 436-438
Authors:
VRIESENDORP HM
QUADRI SM
ANDERSSON BS
WYLLIE CT
DICKE KA
Citation: Hm. Vriesendorp et al., RECURRENCE OF HODGKINS-DISEASE AFTER IN-111 AND Y-90 LABELED ANTIFERRITIN ADMINISTRATION, Cancer, 80(12), 1997, pp. 2721-2727
Authors:
KHOURI IF
PRZEPIORKA D
VANBESIEN K
OBRIEN S
PALMER JL
LERNER S
MEHRA RC
VRIESENDORP HM
ANDERSSON BS
GIRALT S
KORBLING M
KEATING MJ
CHAMPLIN RE
Citation: If. Khouri et al., ALLOGENEIC BLOOD OR MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - TIMING OF TRANSPLANTATION AND POTENTIAL EFFECT OF FLUDARABINEON ACUTE GRAFT-VERSUS-HOST DISEASE, British Journal of Haematology, 97(2), 1997, pp. 466-473
Authors:
POPAT U
ANDERSSON BS
VANBESIEN K
SMITH T
AMIN K
HUGHES P
FAHMI H
GIRALT S
MEHRA R
PRZEPIORKA D
KHOURI I
GAJEWSKI J
CLAXTON D
RODRIGUEZ M
ROMAGUERA J
HAGEMEISTER F
CABANILLAS F
CHAMPLIN RE
Citation: U. Popat et al., ABMT IN RECURRENT OR REFRACTORY HD - LONG-TERM RESULTS, Blood, 90(10), 1997, pp. 500-500
Authors:
ANDERSSON BS
HAI T
MADDEN T
CAGNONI P
JONES R
BRUTON J
MARTINKA S
HOLBERT K
GIRALT S
PRZEPIORKA D
LENNON S
SPILKER B
GIAN V
WINGARD J
TARANTOLO S
KASHYAP A
FORMAN S
CHAMPLIN RE
Citation: Bs. Andersson et al., ALLOGENEIC TRANSPLANTATION IN ADVANCED HEMATOLOGIC MALIGNANCIES AFTER-IV BUSULFAN CYCLOFOSFAMIDE (BUCY), Blood, 90(10), 1997, pp. 1003-1003
Authors:
ANDERSSON BS
SADEGHI T
SICILIANO MJ
LEGERSKI R
MURRAY D
Citation: Bs. Andersson et al., NUCLEOTIDE EXCISION-REPAIR GENES AS DETERMINANTS OF CELLULAR-SENSITIVITY TO CYCLOPHOSPHAMIDE ANALOGS, Cancer chemotherapy and pharmacology, 38(5), 1996, pp. 406-416
Authors:
BHAGWATWAR HP
PHADUNGPOJNA S
CHOW DSL
ANDERSSON BS
Citation: Hp. Bhagwatwar et al., FORMULATION AND STABILITY OF BUSULFAN FOR INTRAVENOUS ADMINISTRATION IN HIGH-DOSE CHEMOTHERAPY, Cancer chemotherapy and pharmacology, 37(5), 1996, pp. 401-408
Authors:
VIDAL RF
EKSBORG S
SUNDBERG M
CARLBERG M
ELFSSON B
ANDERSSON BS
Citation: Rf. Vidal et al., DOXORUBICIN-INDUCED AND DAUNORUBICIN-INDUCED ENERGY DEPRIVATION AND NUCLEOTIDE DEGRADATION IN ISOLATED CARDIOMYOCYTES, Toxicology, 114(1), 1996, pp. 1-10
Authors:
ANDERSSON BS
VIDAL RF
SUNDBERG M
RAJS J
SOTONYI P
Citation: Bs. Andersson et al., HYDROPEROXIDE-INDUCED NUCLEOTIDE DEGRADATION AND ADENOSINE FORMATION IN ISOLATED RAT CARDIOMYOCYTES, Toxicology, 106(1-3), 1996, pp. 39-48
Authors:
ANDERSSON BS
MADDEN T
STANFIELD L
HU W
CHOW DSL
BLUME K
WILLIAMS TE
VAUGHAN WP
CHAMPLIN RE
Citation: Bs. Andersson et al., PRETRANSPLANTATION CONDITIONING THERAPY WITH IV BUSULFAN CYCLOPHOSPHAMIDE (BUCY) - A PHASE-I STUDY/, Blood, 88(10), 1996, pp. 2372-2372
Authors:
VANBESIEN KW
MEHRA RC
GIRALT SA
KANTARJIAN HM
PUGH WC
KHOURI IF
MOON Y
WILLIAMS P
ANDERSSON BS
PRZEPIORKA D
MCCARTHY PL
GAJEWSKI JL
DEISSEROTH AB
CABANILLAS FF
CHAMPLIN R
Citation: Kw. Vanbesien et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR POOR-PROGNOSIS LYMPHOMA - RESPONSE, TOXICITY, AND SURVIVAL DEPEND ON DISEASE HISTOLOGY, The American journal of medicine, 100(3), 1996, pp. 299-307
Authors:
ANDERSSON BS
COLLINS VP
KURZROCK R
LARKIN DW
CHILDS C
OST A
CORK A
TRUJILLO JM
FREIREICH EJ
SICILIANO MJ
DEISSEROTH AB
Citation: Bs. Andersson et al., KBM-7, A HUMAN MYELOID-LEUKEMIA CELL-LINE WITH DOUBLE PHILADELPHIA CHROMOSOMES LACKING NORMAL C-ABL AND BCR TRANSCRIPTS, Leukemia, 9(12), 1995, pp. 2100-2108
Authors:
VANBESIEN KW
KHOURI IF
GIRALT SA
MCCARTHY P
MEHRA R
ANDERSSON BS
PRZEPIORKA D
GAJEWSKI JL
BELLARE N
NATH R
ROMAGUERA JE
MCLAUGHLIN P
KORBLING M
DEISSEROTH AB
CABANILLAS FF
CHAMPLIN RE
Citation: Kw. Vanbesien et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR REFRACTORY AND RECURRENT LOW-GRADE LYMPHOMA - THE CASE FOR AGGRESSIVE MANAGEMENT, Journal of clinical oncology, 13(5), 1995, pp. 1096-1102
Authors:
ANDERSSON BS
MROUE M
BRITTEN RA
FARQUHAR D
MURRAY D
Citation: Bs. Andersson et al., MECHANISMS OF CYCLOPHOSPHAMIDE RESISTANCE IN A HUMAN MYELOID-LEUKEMIACELL-LINE, Acta oncologica, 34(2), 1995, pp. 247-251
Authors:
SEN S
ZHOU HY
ANDERSSON BS
CORK A
FREIREICH EJ
STASS SA
Citation: S. Sen et al., P53 GENE-MUTATIONS WITH CHROMOSOME-17 ABNORMALITIES IN CHRONIC MYELOGENOUS LEUKEMIA BLAST CRISIS PATIENTS PERSIST IN LONG-TERM CELL-LINES BUT MAY BE ACQUIRED IN ACUTE MYELOID-LEUKEMIA CELLS IN-VITRO, Cancer genetics and cytogenetics, 82(1), 1995, pp. 35-40